← back to search

Zhanzhao Fu

Hebei Agricultural University · CN
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Gastric Cancer Management and Outcomes, and Lung Cancer Diagnosis and Treatment.
h-index
22
citations
1,426
works
82
NIH funding
primary concept
email

Recent publications

Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p/VEGFA and HuR/ZO-1 axes in esophageal squamous cell carcinoma
Cell Death Discovery 2024cited by 26position: middledoi
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)
Journal of Gastrointestinal Oncology 2022cited by 5position: middledoi
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
Translational Oncology 2020cited by 32position: middledoi
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)
Therapeutic Advances in Medical Oncology 2020cited by 21position: middledoi
Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202).
PubMed 2020cited by 15position: middle
Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
Journal of Experimental & Clinical Cancer Research 2019cited by 131position: lastdoi
Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and <scp>PD</scp>‐1<sup>high</sup> Breg cells
Cancer Science 2019cited by 64position: lastdoi
Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer.
Journal of Clinical Oncology 2018cited by 2position: middledoi
Apatinib in patients with adenocarcinoma of stomach or gastroesophageal junction: A prospective, multicenter, non-interventional study (Ahead-G202).
Journal of Clinical Oncology 2018cited by 1position: middledoi
Significance of plasma D-dimer and lipoproteins level in patients with gastrointestinal cancer
中国综合临床 2014cited by 0position: lastdoi
EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis
Tumor Biology 2013cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiubao Ren · Tianjin Medical University Cancer Institute and Hospital3 papers (2018–2020) · 3 papers (2019–2024)Ruixing Zhang · Hebei Medical University3 papers (2018–2020)Liwen Ma · Southwest University3 papers (2018–2020)Chunmei Bai · Guangxi University3 papers (2018–2020)Mudan Yang · Ningbo University2 papers (2018–2018)Junyan Yu · Philadelphia University2 papers (2018–2018)Yuchuan Ren · China Pharmaceutical University2 papers (2018–2018)Aimin Zang · Gilead Sciences (France)2 papers (2018–2018) · 2 papers (2018–2018)Xin Li · Heilongjiang Vocational Institute of Ecological Engineering2 papers (2019–2019)Qiang Zhang · University of Shanghai for Science and Technology2 papers (2019–2019)Yimin Wang · Union Hospital2 papers (2019–2019) · 2 papers (2018–2020)Nan Du · Sun Yat-sen University Cancer Center2 papers (2018–2018)Yu Mao · Shandong University2 papers (2019–2019)Lei Zhang · Nanjing University of Chinese Medicine2 papers (2018–2018)Jun Guo · Hebei Medical University2 papers (2018–2018)Junmei Jia · Shanxi Medical University2 papers (2018–2018)Jinghua Gao · Jinan University2 papers (2018–2018)